Skip to search.
 BSE Up 0.86% NSE Up 1.01%

More On AEZS

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Aeterna Zentaris Inc. (AEZS)

-NasdaqCM
0.28 Down 0.01(2.14%) 1:30am
|After Hours : 0.28 0.00 (0.00%) 2:37am - Nasdaq Real Time Price
Add to Portfolio
Prev Close:0.28
Open:0.28
Bid:0.26 x 50000
Ask:0.28 x 37000
1y Target Est:1.43
Beta:1.92
Next Earnings Date:N/A
Day's Range:0.27 - 0.28
52wk Range:0.26 - 1.54
Volume:3,839,931
Avg Vol (3m):3,651,410
Market Cap:26.37M
P/E (ttm):N/A
EPS (ttm):-0.35
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for AEZS at this time.

Comparison

Symbol% ChgMkt Cap
AEZSDown 2.14%26.37M
CELGUp 2.15%93.77B
ENMD 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):320.79
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.33
Quarterly EPS Est (Jun-15) :-0.08
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women's health. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback